December 20, 2013
Cephalon Inc. filed suit in Delaware federal court Thursday alleging rival Hetero Labs Ltd.'s plans to manufacture a generic form of its cancer treatment Treanda violated a patent for the drug, the second infringement suit the Pennsylvania-based pharmaceuticals maker has brought over Treanda in two months.